Cargando…
Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first‐line antihypertensive therapy
Homocysteine is an independent risk factor for cardiovascular and cerebrovascular disease and has been proposed to contribute to vascular dysfunction. We sought to determine in a real‐world clinical setting whether homocysteine levels were associated with hypertension mediated organ damage (HMOD) an...
Autores principales: | Carnagarin, Revathy, Nolde, Janis M., Ward, Natalie C., Lugo‐Gavidia, Leslie Marisol, Chan, Justine, Robinson, Sandi, Jose, Ancy, Joyson, Anu, Azzam, Omar, Galindo Kiuchi, Márcio, Mwipatayi, Bibombe P., Schlaich, Markus P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678735/ https://www.ncbi.nlm.nih.gov/pubmed/34137162 http://dx.doi.org/10.1111/jch.14265 |
Ejemplares similares
-
Machine learning powered tools for automated analysis of muscle sympathetic nerve activity recordings
por: Nolde, Janis M., et al.
Publicado: (2021) -
Association between body fat composition and hyperhomocysteinemia in the analysis of the baseline data of the Northwest China Natural Population Cohort: Ningxia Project (CNC‐NX)
por: Liu, Wanlu, et al.
Publicado: (2023) -
Supine blood pressure—A clinically relevant determinant of vascular target organ damage in hypertensive patients
por: Nolde, Janis M., et al.
Publicado: (2020) -
Sympathetic Activation in Hypertensive Chronic Kidney Disease – A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2020) -
Microvascular changes at different stages of chronic kidney disease
por: Kannenkeril, Dennis, et al.
Publicado: (2020)